Company’s AI approach identifies hidden cancers years before symptoms appear and spares low-risk patients from unnecessary procedures
C the Signs, the creator of an Artificial Intelligence (AI)-based platform to identify patients at risk of cancer at the earliest and most curable stage, announced $8 million in funding from Khosla Ventures....
The organizations plan to support clients through expanded partnership and offer broader access to Medidata's AI-powered technologies to accelerate clinical trial development
Cognizant announced an expanded agreement with Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, to provide support for Medidata's life sciences clients and...
OSE Immunotherapeutics and Scienta Lab Establish Strategic Partnership to Leverage Artificial Intelligence in Precision Immunotherapy
OSE Immunotherapeutics SA and Scienta Lab, a leader in Artificial Intelligence (AI)-driven precision immunology, announce a strategic collaboration to harness Scienta Lab’s advanced AI platform for modeling inflammatory diseases and identifying predictive biomarkers of efficacy...
New Capabilities aim to strengthen corporate profile for strategic transactions and reinforce ongoing partnering discussions
TME Pharma N.V., a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), announced a collaboration with aimed analytics, a cutting-edge medical data analytics company. This...
AlphaMeld Corporation, a global leader in the application of artificial intelligence (AI), machine learning (ML), and generative AI tools to revolutionize drug discovery and development, announced the continuation and expansion of its collaboration with Kyowa Kirin Co., Ltd. (Kyowa Kirin), a Japan-based global specialty pharmaceutical company. The enhanced partnership...
Inato, the leading platform for clinical trial access and inclusivity, unveiled new capabilities to help research sites efficiently pre-screen patients for trial opportunities. The company's latest advancement integrates a series of artificial intelligence (AI) models into a unified agent that quickly and securely reviews patient records and assesses eligibility,...
Ryght AI, a leading provider of real-time generative AI solutions for the clinical research industry, and Cancer Research South Australia (CRSA), a premier cancer care provider, have announced a strategic partnership to advance cancer clinical trials in South Australia. Through this collaboration, CRSA will join the Ryght Research Network, leveraging...
New modular Opentrons Flex® Stacker offers benchtop workstation even more flexibility for all throughput needs
Opentrons Labworks, Inc., a leader in lab automation and accessible robotics, announced the launch of its Opentrons Flex High-Throughput NGS Workstation. The only high-throughput benchtop instrument of its kind available at less than $100K, it...
Researchers can easily track and isolate bit.bio's consistent, defined, and scalable human iPSC-derived cells for the first time, opening up new applications in neurodegenerative drug discovery.
bit.bio, the global leader in cell programming technology, announces the launch of its ioTracker Cells range, starting with GFP ioMicroglia, a progressive tool designed...
Nicoya®, a pioneering life science instrument company specializing in innovative biosensor technologies, announces the launch of the Alto Automation Suite™ for its flagship Alto Digital SPR™ system. This makes Alto the world’s first SPR platform that is fully compatible with standard lab automation, enabling thousands of samples per week...
